3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Xeroderma Pigmentosum
1
Uterine Cervical Dysplasia
1
Trichothiodystrophy Syndromes
1
Squamous Intraepithelial Lesions
1
Sexuality
1
Oligodendroglioma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hematopoietic and Lymphatic System Neoplasm
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Endometrial Neoplasms
1
DNA Repair-Deficiency Disorders
1
Cockayne Syndrome
1
Carcinoma, Endometrioid
1
Breast Cancer Survivors
1
Bone Neoplasms
1
Atypical Squamous Cells of the Cervix
1
Astrocytoma
1
Interventions
pembrolizumab
60
Cisplatin
43
Cetuximab
25
Carboplatin
24
Paclitaxel
19
Magnetic Resonance Spectroscopy
18
Radiotherapy, Intensity-Modulated
17
Nivolumab
16
Radiotherapy
15
Specimen Handling
14
Docetaxel
13
Platinum
12
1,2-diaminocyclohexaneplatinum II citrate
11
Taxes
8
Fluorouracil
8
Biopsy
7
atezolizumab
6
Radiation
6
(225)Ac-DOTA-c(RGDyK)
6
dostarlimab
5
cemiplimab
5
Ipilimumab
5
Standard of Care
4
Immunoglobulin G
4
Disulfides
4
Cyclophosphamide
4
Bevacizumab
4
Albumin-Bound Paclitaxel
4
130-nm albumin-bound paclitaxel
4
toripalimab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Squamous Cell Carcinoma of Head and Neck
×
Restraint, Physical
×
90 days
×
Clear all
No trials found.